Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 26.91%12.6M | 37.06%9.93M | 15.38%7.25M | 48.28%6.28M | -32.73%4.23M | -20.29%6.3M | 10.72%7.9M | -3.24%7.13M | -16.57%1.58M | 2.09M |
| Cost of revenue | 8.42%3.87M | 10.62%3.57M | 2.40%3.22M | 26.79%3.15M | -25.78%2.48M | -11.62%3.35M | 41.49%3.79M | -22.81%2.68M | -25.24%622.2K | 693K |
| Gross profit | 37.28%8.74M | 58.27%6.36M | 28.43%4.02M | 78.77%3.13M | -40.61%1.75M | -28.28%2.95M | -7.75%4.11M | 14.15%4.46M | -9.82%961.91K | 1.39M |
| Operating expense | 5.08%2.81M | -9.01%2.67M | 5.31%2.93M | 5.84%2.79M | 29.75%2.63M | -9.84%2.03M | 22.06%2.25M | 70.93%1.84M | 1,528.00%447.49K | 497K |
| Selling and administrative expenses | -5.97%2.44M | -8.11%2.6M | 0.79%2.82M | 8.33%2.8M | 33.73%2.59M | -11.58%1.93M | 37.62%2.19M | 29.66%1.59M | ---- | ---- |
| -Selling and marketing expense | -5.48%25.79K | 32.47%27.28K | 38.11%20.59K | -66.41%14.91K | -17.61%44.39K | 41.09%53.88K | 11.82%38.19K | -74.43%34.15K | ---- | ---- |
| -General and administrative expense | -5.97%2.41M | -8.40%2.57M | 0.60%2.8M | 9.63%2.79M | 35.20%2.54M | -12.52%1.88M | 38.18%2.15M | 42.38%1.56M | ---- | ---- |
| Other operating expenses | 391.45%364.66K | -32.40%74.2K | 302.09%109.77K | -72.50%27.3K | 5.00%99.27K | 51.19%94.54K | -75.37%62.53K | 329.08%253.88K | 9.22%-125.12K | ---544K |
| Total other operating income | 432.65%261K | --49K | --0 | -19.44%43.2K | --53.63K | --0 | ---- | ---- | ---- | ---- |
| Operating profit | 60.54%5.93M | 239.97%3.69M | 215.47%1.09M | 139.09%344.41K | -195.78%-881.11K | -50.58%919.89K | -28.78%1.86M | -7.53%2.61M | -50.49%514.42K | 895K |
| Net non-operating interest income (expenses) | 3,858.58%263.01K | 218.28%6.64K | 62.30%-5.62K | -14.72%-14.9K | -210.42%-12.99K | -112.47%-4.18K | -25.68%33.55K | 45.14K | 11.14K | 34K |
| Non-operating interest income | 1,283.76%297.38K | 111.21%21.49K | --10.18K | --0 | -87.67%550 | -86.71%4.46K | -25.68%33.55K | --45.14K | --11.14K | ---- |
| Non-operating interest expense | 131.53%34.38K | -5.98%14.85K | 5.99%15.79K | 10.06%14.9K | 56.64%13.54K | --8.64K | ---- | ---- | ---- | ---- |
| Net investment income | -59.64%92.25K | 144.53%228.6K | -38.87%93.49K | -11.00%152.92K | -27.37%171.81K | -13.95%236.55K | 274.9K | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -28.38%174.75K | 124.76%243.99K | 108.55K | 0 | -36.76%43 | 68 | 0 | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -89.56%76K | 327.27%727.65K | 166.09%170.3K | 64K | ||||||
| Less:Write off | 89.56%-76K | -327.27%-727.65K | -166.09%-170.3K | ---64K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 3,001.69%16.53K | -94.08%533 | 9K | |||||||
| Income before tax | 33.70%6.55M | 235.19%4.9M | 167.60%1.46M | 175.65%546.43K | -162.68%-722.28K | -46.89%1.15M | -18.38%2.17M | -5.93%2.66M | -47.19%525.56K | 929K |
| Income tax | 37.77%1.46M | 284.67%1.06M | 331.92%276.43K | 727.84%64K | -75.59%7.73K | 492.68%31.67K | -43.79%5.34K | 31.62%9.51K | 12.78%2.51K | 2K |
| Net income | 32.57%5.09M | 223.65%3.84M | 145.80%1.19M | 166.08%482.43K | -165.14%-730.01K | -48.23%1.12M | -18.29%2.16M | -6.02%2.65M | -47.32%523.06K | 927K |
| Net income continuous operations | 32.57%5.09M | 223.65%3.84M | 145.80%1.19M | 166.08%482.43K | -165.14%-730.01K | -48.23%1.12M | -18.29%2.16M | -6.02%2.65M | -47.32%523.06K | --927K |
| Noncontrolling interests | 0 | 0 | -440.69%-80.97K | 23.77K | ||||||
| Net income attributable to the company | 32.57%5.09M | 223.65%3.84M | 145.80%1.19M | 174.33%482.43K | -159.17%-649.04K | -49.32%1.1M | -18.29%2.16M | -6.02%2.65M | -47.32%523.06K | 927K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 32.57%5.09M | 223.65%3.84M | 145.80%1.19M | 174.33%482.43K | -159.17%-649.04K | -49.32%1.1M | -18.29%2.16M | -6.02%2.65M | -47.32%523.06K | 927K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 32.17%0.0341 | 222.50%0.0258 | 150.00%0.008 | 172.73%0.0032 | -159.46%-0.0044 | -49.66%0.0074 | -33.48%0.0147 | -5.83%0.0221 | -5.25%0.0078 | 0.0045 |
| Diluted earnings per share | 32.17%0.0341 | 222.50%0.0258 | 150.00%0.008 | 172.73%0.0032 | -159.46%-0.0044 | -49.66%0.0074 | -33.48%0.0147 | -5.83%0.0221 | -52.81%0.0039 | 0.0045 |
| Dividend per share | 20.00%0.006 | 100.00%0.005 | 0.0025 | 0 | 0 | 0.00%0.004 | 0.004 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.